marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Reata Pharmaceuticals Kennzahlen 2011-2024 | RETA
Kennzahlen Jährlich Reata Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.3 | -3.4 | -14.1 | -20.3 | -26.5 | -14.5 | -79.5 | - | - | - | - | - |
P/S |
741.9 | 88.9 | 387.2 | 222.6 | 39.8 | 14.4 | 9.9 | - | - | - | - | - |
EPS |
-8.5 | -8.2 | -7.3 | -9.5 | -2.9 | -2.0 | -0.3 | -0.1 | 0.0 | - | - | - |
EV (Enterprise Value) |
1.6 B | 431 M | 2.67 B | 5.66 B | 2.13 B | 846 M | 715 M | 310 M | 312 M | 507 M | - | - |
EBITDA per Share |
0.03 | 0.03 | 0.03 | -9.35 | -2.76 | -1.94 | -0.313 | - | - | - | - | - |
EV/EBITDA |
354.7 | -13.0 | -19.0 | -24.5 | -12.6 | -66.2 | - | - | - | - | - | |
PEG |
-0.03 | -1.04 | 0.09 | 0.57 | 0.03 | 4.56 | - | - | - | - | - | |
P/B |
3.2 | 1.4 | 4.1 | 23.0 | 140.7 | -4.7 | -2.3 | - | - | - | - | - |
P/CF |
-8.0 | -4.3 | -10.8 | -23.3 | -25.3 | -8.3 | -25.3 | - | - | - | - | - |
ROE % |
474.77 | -159.89 | -59.35 | -112.97 | -531.34 | 32.44 | 2.90 | - | - | - | - | - |
ROA % |
-60.62 | -40.46 | -28.89 | -42.52 | -23.33 | -35.22 | -6.99 | - | - | - | - | - |
ROCE % |
- | - | - | -58.16 | -26.57 | -53.48 | -23.36 | - | - | - | - | - |
Current Ratio |
- | - | - | 3.5 | 6.1 | 2.8 | 1.5 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 5.6 | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | -5.6 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich Reata Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-3.14 | - | -2.16 | -2.02 | -2.03 | - | -1.97 | -2 | -1.86 | -1.9 | -1.94 | -2.03 | -1.47 | -5.91 | -1.32 | -1.14 | -0.98 | -0.86 | -1.07 | -1.08 | 0.16 | -0.64 | -0.5 | -0.52 | -0.32 | -0.19 | -0.04 | -0.05 | -0.02 | -0.11 | 0.04 | -0.11 | 0.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - | - | - | - | - | - | - | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.03 | 0.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-3517.07 | -1914.33 | -1942.40 | -221.09 | -137.09 | -69.50 | -85.25 | -72.87 | -65.89 | -59.35 | -116.37 | -116.15 | -113.34 | -112.97 | -208.95 | -396.90 | -569.62 | -531.34 | -351.24 | -139.45 | 54.53 | 32.44 | 23.01 | 15.06 | 7.61 | 2.90 | 1.61 | 0.96 | 1.15 | 1.03 | 0.39 | 0.62 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-64.32 | -36.04 | -45.86 | -42.14 | -39.84 | -27.44 | -35.11 | -32.93 | -31.46 | -28.89 | -48.61 | -46.80 | -43.96 | -42.52 | -22.54 | -25.65 | -28.79 | -23.33 | -28.24 | -28.40 | -28.80 | -35.22 | -27.55 | -19.46 | -11.94 | -6.99 | -4.56 | -2.75 | -3.85 | -3.56 | -1.35 | -2.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 268.5 | 342.1 | 38.5 | 4.6 | - | 3.6 | 3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 268.5 | 342.1 | 38.5 | 4.6 | - | 3.6 | 3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 268.5 | 342.1 | 38.5 | 4.6 | - | 3.6 | 3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung